Navigation Links
The Acta Materialia Inc Announces New Chairman of the Board of Governors

NEW YORK, September 6, 2012 /PRNewswire/ --

Dr George "Rusty" Gray II to further nurture Acta's three leading journals in the material sciences: Acta Materialia, Scripta Materialia, and Acta Biomaterialia

Acta Materialia Inc. is pleased to announce that Dr George "Rusty" Gray II has been appointed as Chairman of the Board of Governors of Acta Materialia Inc. effective immediately. He succeeds Dr William F. Scott who passed away June 25, 2012.

Rusty, a native of New York, earned his PhD from Carnegie-Mellon University in 1981 and is currently a Laboratory Fellow and staff member in the dynamic properties and constitutive modeling team within the Materials Science Division of Los Alamos National Laboratory. He has served as the TMS representative on the Acta Board of Governors since 2004.

Dr Gray said of his appointment, "I am honored and excited to serve as the Chair of the Board of Governors of Acta Materialia, Inc. and look forward to nurturing and growing the strengths represented by Acta's three journals to keep them at the forefront of the rapidly evolving research topics in materials science and engineering research."

Founded in 1953, the Acta Materialia Inc., in collaboration with Elsevier, publish three high quality journals, Acta Materialia, Scripta Materialia, and Acta Biomaterialia, which cover the areas of materials science, biomaterials, materials engineering, and materials chemistry and physics. Acta Materialia is the leading journal in its field with an impact factor of 3.755. Acta Materialia Inc. supports and promotes scientific meetings, award prizes, and undertakes other activities to further its fundamental purpose and promote the science and engineering of materials science.

"Rusty is still very active in research, is familiar with contemporary issues in materials research, and the three journals will benefit substantially from his demonstrated leadership," stated Subhash Mahajan,Coordinating Editor of the journals at  Acta Materialia Inc.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Allyn Molina

SOURCE Elsevier
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes
2. RayBiotech, Inc. Achieves Both GMP- and GLP-Compliance and Announces New Dedicated Services Laboratory
3. Tufts Medical Center Announces Inaugural INNOVATION Day: Innovating a Path to Market
4. ESTEVE Announces the Publication of Comprehensive Phase I Data for a Novel Oral, First-in-class New Chemical Entity (NCE),E-52862, a Sigma-1 Receptor Antagonist (S1RA) Being Developed for Pain
5. Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts
6. Sangamo BioSciences Announces Presentation At The Stifel Nicolaus 2012 Healthcare Conference
7. ARMGO Pharma, Inc. announces data which supports its Rycal program as a novel approach for the treatment of stress-induced cognitive disorders
8. Bolder BioTechnology Announces Publication of Data Demonstrating Utility of the Companys Long-Acting IL-11 Analog to Prevent Renal Ischemia Reperfusion Injury
9. Clinical Site Services, Industry Leader in Patient Enrollment Solutions, Announces New Website
10. Debiopharm Announces First Patient Enrolled in Phase III Study for the Rare Disease Central Precocious Puberty
11. Pinnaclife, Inc., Announces NDC, Inc., to Exclusively Distribute the New Animal Health Product Line!
Post Your Comments:
(Date:11/30/2015)... Partnership includes an MPP ... the u niversity , s Solid Drug Nanoparticle (SDN) ... - up through cost cuts ... , where licensees based anywhere in the world will have the right to make, ... Africa , where licensees based anywhere in the world will have the right ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... touring exhibition Jurassic World: The Exhibition, opening in March 2016 at Melbourne Museum ... a worldwide tour including several North American tour dates. The Exhibition is based ...
(Date:11/30/2015)... , Nov. 30, 2015  Aytu BioScience, Inc. (OTCQB: ... and related conditions, will present at two upcoming investor ... an interactive real-time virtual conference, to be held December ... Conference, to be held December 2 nd & ... and streamed live via webcast. ...
(Date:11/30/2015)... TIKVAH, Israel , Nov. 30, 2015 /PRNewswire/ ... a leading developer of adult stem cell technologies for neurodegenerative ... Ltd., has been awarded an additional grant of approximately $735,000 ... Scientist (OCS). This grant, the second this year, brings the ... approximately $1.8 million (approximately NIS7 million).  ...
Breaking Biology Technology:
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , ... spectrum of clinical research, is pleased to announce that it ... Clinical Trials (PCT) event, to be held November 17-19 ... able to view live demonstrations of iMedNet ... learn how iMedNet has been able to deliver ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):